"We Envision Growth Strategies Most Suited
to Your Business"
The global bone graft substitutes market size is poised to reach USD 3.93 billion by 2027 attributed to the increasing incidence of tooth decay or weak tooth structure. A rise in the application of bone graft for tooth replacement, jawbone strengthening, dental implants, and other dentistry-related techniques are aiding to the expansion of this market. A recent report by Fortune Business Insights, titled, “Bone Graft Substitutes Market Size, Share & Industry Analysis, By Type (Autograft, Allograft, Demineralized bone matrix (DBM), Synthetic, Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, Others), By End User (Hospitals, Specialty Clinics) and Regional Forecasts, 2020-2027,” states that the market value was USD 3.18 billion in 2019 and is likely to rise at a CAGR of 5.1% between 2020 to 2027.
Japan Hosts Launch of First DBM Product by Medtronic for Orthopedic Treatment
Medtronic Plc., a leading company dealing with medical device manufacturing, announced the launch of a new DMB bone grafting product called Grafton (TM) in Japan in February 2019. This new demineralized bone matrix (DBM) product is the first of its kind and the only one available in Japan. The Grafton was approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in August 2018. This product is a bone graft extender and helps to fill the gaps found in the pelvis, spine, or other extremities. The senior VP and President of the Spine Division, Medtronic, states, “The Grafton DBM will help surgeons to suffice to the demand of each patient and their unique medical demands, further attributed to its high osteoinductivity and an unmatched combination of biologic therapies. We are creating three forms of Grafton for ailing to different needs of orthopedic patients. These include Grafton Matrix Strip, Grafton Matrix, and Grafton Putty.”
This product has been utilized for more than a billion procedures around the world. It is commercially available in Latin America, the Middle East, Europe, Korea, Australia, the U.S., and other parts. Such initiatives are likely to bode well for this market in the coming years.
To get a detailed report summary and research scope of this market, click here:
Increasing Investments in Research and Development of Novel Bone Grafts to Propel Growth
The increasing number of accidents and trauma cases are the key factors promoting the bone graft substitutes market growth. Additionally, the growing incidence of spinal cord injury is also adding impetus to the market. The increasing investment in research and development of new bone grafts is expected to aid in the expansion of the market.
On the flip side, certain side effects of bone grafting such as infection, blood clot, nerve damage, infection derived from the donor, and others may pose a significant hindrance to the market. Nevertheless, the increasing geriatric population and their vulnerability to various disorders of the joints and bones will help the market for bone graft substitutes to exhibit lucrative growth opportunities in the coming years.
Players Emphasizing on Investing in Research and Development Activities to Strive for Lion’s Share
The presence of many players has resulted in a fragmented nature of the market for bone graft substitutes. Most companies are engaging in merger and acquisition, joint ventures, contracts and agreements, and other collaborative efforts to gain a significant position in the market. Others are investing massively on research and development of novel bone grafting techniques to attract high revenues to their brand name, thereby contributing to the overall growth of the market.
Key Industry Developments of Market Include:
List of Prominent Players in the Market for Bone Graft Substitutes Include:
Further Report Findings:
The Global Market is categorized into:
Value (USD billion)
By End User